Tag: Investigational drugs

Recent studies have identified multiple potential drug candidates for myelin repair, highlighting a shift toward restorative therapies rather than solely managing symptoms. While there is no single consensus on **what is the best drug for myelin sheath repair**, significant research is underway to develop treatments for demyelinating diseases like multiple sclerosis.

Based on recent clinical trial findings, Efpeglenatide, an investigational glucagon-like peptide-1 receptor agonist (GLP-1 RA), has demonstrated significant improvements in glycemic control and body weight loss for patients with type 2 diabetes (T2D). The drug’s potential indications extend beyond blood sugar management, showing promising results for reducing cardiovascular and renal risks in high-risk patient populations.

Initially developed to treat Alzheimer's disease, Gamma-Secretase Inhibitors (GSIs) have been repurposed as potential anticancer agents because they inhibit Notch receptor cleavage [1.2.1]. This article explores the question: What is a GSI pill used for? and examines its mechanisms, applications, and clinical status.